| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 8,871 | 14,700 | 14,742 | 14,997 | | Cost of Revenue | 3,801 | 4,047 | 4,041 | 4,009 | | | Gross Profit |
-
| 10,653 | 10,700 | 10,988 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,289 | 6,028 | 5,368 | 5,298 | | Non Recurring |
-
|
-
|
-
| 688 | | Others | 9,031 | 3,631 | 339 | 8,945 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 995 | 4,993 | (3,943) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (9,250) | 995 | 4,993 | (3,943) | | Interest Expense | 1,815 | 1,925 | 2,099 | 2,397 | | Income Before Tax | (11,065) | (931) | 2,894 | (6,341) | | Income Tax Expense | (4,089) | (553) | 742 | (2,417) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,976) | (378) | 2,152 | (3,923) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (6,976) | (378) | 2,152 | (3,923) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($6,976) | ($378) | $2,152 | ($3,923) |
|
0.51% Nasdaq 
0.09 (1.34%) 
Income Statement
